Cargando…

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus

Persistent, high-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer. Neutralizing antibodies elicited by L1-only virus-like particles (VLPs) can block HPV infection; however, the lack of high-resolution structures has limited our understanding of the mode of virus infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhihai, Wang, Daning, Gu, Ying, Song, Shuo, He, Maozhou, Shi, Jingjie, Liu, Xinlin, Wei, Shuangping, Li, Jinjin, Yu, Hai, Zheng, Qingbing, Yan, Xiaodong, Baker, Timothy S., Zhang, Jun, McLellan, Jason S., Li, Shaowei, Xia, Ningshao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615192/ https://www.ncbi.nlm.nih.gov/pubmed/28951471 http://dx.doi.org/10.1128/mBio.00787-17

Ejemplares similares

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
por: Li, Zhihai, et al.
Publicado: (2018)

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection
por: Liu, Xinlin, et al.
Publicado: (2019)

Viral neutralization by antibody-imposed physical disruption
por: Zheng, Qingbing, et al.
Publicado: (2019)

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding
por: He, Maozhou, et al.
Publicado: (2021)

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
por: Wei, Minxi, et al.
Publicado: (2018)

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
por: Wang, Daning, et al.
Publicado: (2020)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody
por: Wang, Daning, et al.
Publicado: (2015)

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody
por: Xu, Longfa, et al.
Publicado: (2017)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
por: Zhang, Zhiqing, et al.
Publicado: (2018)

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
por: Xia, Lin, et al.
Publicado: (2016)

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
por: Qian, Ciying, et al.
Publicado: (2022)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
por: Li, Tingting, et al.
Publicado: (2021)

Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209
por: Ju, Bin, et al.
Publicado: (2022)

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs
por: Huang, Weijin, et al.
Publicado: (2020)

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
por: Zhao, Dongping, et al.
Publicado: (2022)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
por: Li, Tingting, et al.
Publicado: (2022)

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10
por: Zhu, Rui, et al.
Publicado: (2018)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)

Structures of pseudorabies virus capsids
por: Wang, Guosong, et al.
Publicado: (2022)

Investigation of a special neutralizing epitope of HEV E2s
por: You, Min, et al.
Publicado: (2014)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
por: Liu, Liqin, et al.
Publicado: (2022)

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
por: Huang, Xiaofen, et al.
Publicado: (2021)

Construction of a bacterial surface display system based on outer membrane protein F
por: Chen, Tingting, et al.
Publicado: (2019)

Structural Basis for Binding of Neutralizing Antibodies to Clostridioides difficile Binary Toxin
por: Goldsmith, Jory A., et al.
Publicado: (2023)

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
por: Li, Tingting, et al.
Publicado: (2020)

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
por: Wang, Siling, et al.
Publicado: (2022)

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions
por: Zhou, Lizhi, et al.
Publicado: (2020)

Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes
por: Goldsmith, Jory A., et al.
Publicado: (2021)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
por: Wang, Kaihang, et al.
Publicado: (2021)

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)

Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice
por: Jemon, K., et al.
Publicado: (2016)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Effect of Season and High Ambient Temperature on Activity Levels and Patterns of Grizzly Bears (Ursus arctos)
por: McLellan, Michelle L., et al.
Publicado: (2015)

Comparing Neutral (Monometallic) and Anionic (Bimetallic) Aluminum Complexes in Hydroboration Catalysis: Influences of Lithium Cooperation and Ligand Set
por: Pollard, Victoria A., et al.
Publicado: (2018)

Chimeric Pneumoviridae fusion proteins as immunogens to induce cross‐neutralizing antibody responses
por: Olmedillas, Eduardo, et al.
Publicado: (2017)

Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies
por: Amin, Mohammed N., et al.
Publicado: (2013)

Induction of neutralizing antibodies by human papillomavirus vaccine generated in mammalian cells
por: Wu, Xilin, et al.
Publicado: (2019)

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
por: Huang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vca2rqnovp0l3efbij46juork